company background image
Z1TS34 logo

Zoetis BOVESPA:Z1TS34 Stock Report

Last Price

R$64.38

Market Cap

R$456.6b

7D

2.2%

1Y

5.2%

Updated

06 Feb, 2025

Data

Company Financials +

Zoetis Inc.

BOVESPA:Z1TS34 Stock Report

Market Cap: R$456.6b

Z1TS34 Stock Overview

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. More details

Z1TS34 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health4/6
Dividends0/6

Rewards

Earnings have grown 9.8% per year over the past 5 years

Risk Analysis

Has a high level of debt


My Notes

Capture your thoughts, links and company narrative

Zoetis Inc. Competitors

Hypera

BOVESPA:HYPE3

R$12.0b

GSK

LSE:GSK

UK£60.4b

Ouro Fino Saúde Animal Participações

BOVESPA:OFSA3

R$978.6m

Chugai Pharmaceutical

TSE:4519

JP¥11.1t

Price History & Performance

Summary of share price highs, lows and changes for Zoetis
Historical stock prices
Current Share PriceUS$64.38
52 Week HighUS$70.00
52 Week LowUS$47.10
Beta0.89
1 Month Change4.28%
3 Month Change1.42%
1 Year Change5.20%
3 Year Change-1.23%
5 Year Change62.99%
Change since IPO79.83%

Recent News & Updates

Recent updates

Shareholder Returns

Z1TS34BR PharmaceuticalsBR Market
7D2.2%0.7%-0.6%
1Y5.2%-17.3%-7.3%

Return vs Industry: Z1TS34 exceeded the BR Pharmaceuticals industry which returned -18.6% over the past year.

Return vs Market: Z1TS34 exceeded the BR Market which returned -9.5% over the past year.

Price Volatility

Is Z1TS34's price volatile compared to industry and market?
Z1TS34 volatility
Z1TS34 Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement5.6%
10% most volatile stocks in BR Market9.7%
10% least volatile stocks in BR Market3.2%

Stable Share Price: Z1TS34 has not had significant price volatility in the past 3 months compared to the BR market.

Volatility Over Time: Z1TS34's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195214,100Kristin Peckwww.zoetis.com

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives.

Zoetis Inc. Fundamentals Summary

How do Zoetis's earnings and revenue compare to its market cap?
Z1TS34 fundamental statistics
Market capR$456.59b
Earnings (TTM)R$14.00b
Revenue (TTM)R$52.72b

32.3x

P/E Ratio

8.6x

P/S Ratio

Is Z1TS34 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
Z1TS34 income statement (TTM)
RevenueUS$9.15b
Cost of RevenueUS$2.74b
Gross ProfitUS$6.42b
Other ExpensesUS$3.99b
EarningsUS$2.43b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)5.39
Gross Margin70.09%
Net Profit Margin26.55%
Debt/Equity Ratio126.0%

How did Z1TS34 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

31%

Payout Ratio

Does Z1TS34 pay a reliable dividends?

See Z1TS34 dividend history and benchmarks
When do you need to buy Z1TS34 by to receive an upcoming dividend?
Zoetis dividend dates
Ex Dividend DateJan 20 2025
Dividend Pay DateMar 10 2025
Days until Ex dividend19 days
Days until Dividend pay date30 days

Does Z1TS34 pay a reliable dividends?

See Z1TS34 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 13:51
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zoetis Inc. is covered by 43 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Ishan MajumdarBaptista Research
Balaji PrasadBarclays